Mary Iconomou

674 total citations
9 papers, 392 citations indexed

About

Mary Iconomou is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Mary Iconomou has authored 9 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Oncology and 2 papers in Cancer Research. Recurrent topics in Mary Iconomou's work include Glycosylation and Glycoproteins Research (4 papers), Ubiquitin and proteasome pathways (4 papers) and Peptidase Inhibition and Analysis (3 papers). Mary Iconomou is often cited by papers focused on Glycosylation and Glycoproteins Research (4 papers), Ubiquitin and proteasome pathways (4 papers) and Peptidase Inhibition and Analysis (3 papers). Mary Iconomou collaborates with scholars based in Australia, United States and Germany. Mary Iconomou's co-authors include Darren N. Saunders, Robert F. Shearer, Colin K. W. Watts, John D. Hooper, Yaowu He, J. P. Quigley, Berta Casar, Elena I. Deryugina, David R. Croucher and Samuel Aparício and has published in prestigious journals such as Oncogene, Biochemical Journal and Science Signaling.

In The Last Decade

Mary Iconomou

8 papers receiving 389 citations

Peers

Countries citing papers authored by Mary Iconomou

Since Specialization

Citations

This map shows the geographic impact of Mary Iconomou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Iconomou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Iconomou more than expected).

Fields of papers citing papers by Mary Iconomou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Iconomou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Iconomou. The network helps show where Mary Iconomou may publish in the future.

Co-authorship network of co-authors of Mary Iconomou

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Iconomou. A scholar is included among the top collaborators of Mary Iconomou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Iconomou. Mary Iconomou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	Genetic landscape of T cells identifies synthetic lethality for T-ALL 2021 ·Communications Biology ·Connor P. O’Meara, Lucía Guerri, (unknown), Fernando Mateos, Mary Iconomou, Norimasa Iwanami, Cristian Soza‐Ried, Katarzyna Sikora, (unknown), (unknown), Sarah Peter, Michael Schorpp, Thomas Boehm	6
2	Dissecting Multi-protein Signaling Complexes by Bimolecular Complementation Affinity Purification (BiCAP) 2018 ·Journal of Visualized Experiments ·Jordan F. Hastings, (unknown), Robert F. Shearer, Sean P. Kennedy, Mary Iconomou, Darren N. Saunders, David R. Croucher	1
3	Dissecting Multi-protein Signaling Complexes by Bimolecular Complementation Affinity Purification (BiCAP) 2018 ·Journal of Visualized Experiments ·Jordan F. Hastings, (unknown), Robert F. Shearer, Sean P. Kennedy, Mary Iconomou, Darren N. Saunders, David R. Croucher	0
4	Development of an enzyme-linked immunosorbent assay for detection of CDCP1 shed from the cell surface and present in colorectal cancer serum specimens 2017 ·Journal of Pharmaceutical and Biomedical Analysis ·Yang Chen, Brittney S. Harrington, Kevin Lau, Leslie Burke, Yaowu He, Mary Iconomou, James S. Palmer, (unknown), John W. Lumley, John D. Hooper	10
5	Mitochondrial mutations and metabolic adaptation in pancreatic cancer 2017 ·Cancer & Metabolism ·(unknown), Rae‐Anne Hardie, (unknown), Mark J. Cowley, Ting-Li Han, Seher Balaban, Marina Pajic, Mark Pinese, Mary Iconomou, Robert F. Shearer, (unknown), David S. Miller, Nicola Waddell, John V. Pearson, Sean M. Grimmond, Leonid A. Sazanov, Andrew V. Biankin, Silas G. Villas‐Bôas, Andrew J. Hoy, Nigel Turner, Darren N. Saunders	52
6	Systematic approaches to identify E3 ligase substrates 2016 ·Biochemical Journal ·Mary Iconomou, Darren N. Saunders	128
7	Bimolecular complementation affinity purification (BiCAP) reveals dimer-specific protein interactions for ERBB2 dimers 2016 ·Science Signaling ·David R. Croucher, Mary Iconomou, Jordan F. Hastings, Sean P. Kennedy, (unknown), Robert F. Shearer, (unknown), Adrian Wan, Joseph Lau, Samuel Aparício, Darren N. Saunders	40
8	Functional Roles of the E3 Ubiquitin Ligase UBR5 in Cancer 2015 ·Molecular Cancer Research ·Robert F. Shearer, Mary Iconomou, Colin K. W. Watts, Darren N. Saunders	100
9	Blocking of CDCP1 cleavage in vivo prevents Akt-dependent survival and inhibits metastatic colonization through PARP1-mediated apoptosis of cancer cells 2011 ·Oncogene ·Berta Casar, Yaowu He, Mary Iconomou, John D. Hooper, J. P. Quigley, Elena I. Deryugina	55

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact